LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors

Library search

Written Description Requirement of Patentability
Intellectual PropertyPharmaceutical
One of the requirements for an invention to be patentable is written description, which requires that the invention be described in sufficient detail for one of ordinary skill in the...Read more
Portrait image of Anagha Tendulkar
Anagha Tendulkar
In-house Patent Counsel, Cipla, India
Blocking Effect of the Blocking Act?
CompetitionPharmaceutical
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch Waxman Act 1984, was enacted in 1984 to balance the privileges offered to brand...Read more
Portrait image of Anagha Tendulkar
Anagha Tendulkar
In-house Patent Counsel, Cipla, India
Covid-19 - Fundamental Rights and Freedoms: From the Adoption of Restrictive Measures to the Day-By-Day Management of Companies
EthicsPharmaceutical
The emergency context resulting from the spread of Covid-19, which has involved all continents and national states, has led to the need, in democratic states, of adopting all means and...Read more
Portrait image of Carlo Impalà
Carlo Impalà
Partner, Morri Rossetti & Associati, Italy
Portrait image of Giorgia Valsecchi
Giorgia Valsecchi
Associate of TMT and Data Protection Department, Morri Rossetti & Associati, Italy
Portrait image of Alessandra Capomagi
Alessandra Capomagi
Corporate Data Protection Advisor, Recordati S.p.A, Italy
Managing Compliance Risk in a COVID and Post-COVID World
ManagementPharmaceutical
Managing risk can be complicated in the best of times, and the challenges associated with risk management become even greater when combined with the tremendous disruption caused by a global...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Tatiyana Akers
Tatiyana Akers
Associate Director, Compliance, Aimmune Therapeutics, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Paper Title International Pharma Congresses during Covid-19
ManagementPharmaceutical
Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response...Read more
Portrait image of Geraldine Benjamin
Geraldine Benjamin
English Solicitor, Bailhache Labesse Trustees, UK
GREECE: The claw-back Mechanism
FinancePharmaceutical
In view of the financial crisis of the recent years, Greece was found forced to settle an agreement with its international creditors, which was sealed by a political memorandum of...Read more
Portrait image of Dimitra Lempesi
Dimitra Lempesi
Legal Counsel, Sfee, Greece
The Compulsory Licensing in Russia: The First Precedent Lessons Learned
LicensingPharmaceutical
The compulsory license mechanism in Russia had been described in the Civil Code of the Russian Federation for a long time. However, there had been no real cases of granting...Read more
Portrait image of Elvira Dubovskaya
Elvira Dubovskaya
Fulbright Scholar, N/A, Russia
Legal In-house Digitization/Financial Services
TechnologyPharmaceutical
Many factors are changing legal services as we know them. We are seeing the internal and external environment changing the banking model and business needs. Increased regulatory requirements, the evolving...Read more
Portrait image of Andreas Weber
Andreas Weber
Head Cross-border Legal, Emerging Markets and Change-the Bank, UBS, Ubs, Switzerland
Creating Efficiencies in Drug Discovery and Development Using Artificial Intelligence
Artificial IntelligencePharmaceutical
The recent growth of machine learning applications using artificial intelligence (AI), ranging from drug discovery to improvements in patient care, has coincided with increased investments from pharmaceutical and technology companies....Read more
Portrait image of Priya Mannan
Priya Mannan
Associate General Counsel, Novartis Institutes for Biomedical Research, Switzerland
Making it Stick: How to Provide Legal Advice that Influences Business Decisions
ManagementPharmaceutical
As attorneys, determining the most risk-averse legal advice to give to our business partners often comes naturally. After all, we have both academic and professional experience in considering legal questions. But...Read more
Portrait image of Joshua Axelrod
Joshua Axelrod
Brand Counsel, Celgene Corporation, Ireland
1234…6